Background and Aims: Regulatory Foxp3 + CD4 + T cells [Tregs] have been implicated in the control of colitis in T-cell transfer models, yet their ability to regulate colitis induced by innate immunity and the impact of gut inflammation on their fate and function have been poorly documented. Methods: Colitis was induced by dextran sodium sulphate in DEREG transgenic mice. Tregs ablation and transfer experiments showd that Tregs could limit the severity of colitis in B6 mice. Results: Gut inflammation resulted in increased number of Tregs in mesenteric lymph nodes [MLN] and colon lamina propria [LP], although their frequency decreased due to massive concomitant leukocyte infiltration. This coincided at both sites with a dramatic increase in Ki67 + Tregs which retained proliferative capacity. Gut inflammation resulted in enhanced suppressive function of Tregs in colon lamina propria and neuropillin- 
Introduction
Inflammatory bowel diseases [IBD] are chronic T-cell mediated disorders affecting the small and large intestine, which involve both innate and adaptive arms of the gut immune system. Although there is no animal model that fully mimics human IBD, various experimental models have allowed better insight into its pathophysiology. 1 The T-cell transfer model of colitis in immune-deficient mice and the dextran sodium sulphate [DSS]-induced colitis model are the two most commonly used. The advantage of the DSS-induced colitis model is that acute colitis is generated by activation and recruitment of innate immune cells, and develops in a few days independently of effector T cells in immunocompetent mice, thus allowing examination of the direct impact of gut inflammation on Foxp3 + regulatory T cells [Tregs] . Although this animal model has limitations regarding the accurate representation of the clinical course of IBD, it nevertheless recapitulates the common clinical features of inflammation and histopathology seen in the human disease.
2 DSS-induced colitis manifests by body weight loss, rectal bleeding and diarrhoea. Macroscopic and histological examinations reveal shortening of the intestine, severe epithelial damage with sub-mucosal ulcerations and a dense inflammatory cell infiltration of the colonic mucosa along with excessive production of proinflammatory cytokines.
Regulatory T cells play a pivotal role in the induction and maintenance of mucosal tolerance and gut homeostasis to flora and dietary antigens. 3 Several populations with regulatory properties have been described; however, T cells characterized by expression of CD25, the IL-2 receptor α chain, and the transcription factor Foxp3 [which conditions development and function of Tregs in mice] is the major population of regulatory T cells. [4] [5] [6] Pioneer studies by the group of F. Powrie have established the critical role of Tregs in preventing development of chronic colitis in T-cell transfer models in immunocompromised mice 7 ; however, much less is known regarding the efficacy of Tregs to control acute non-T cell-mediated colitis. Mutation or deficiency of the FOXP3 gene is responsible for immune dysregulation, polyendocrinopathy, enteropathy, X-linked [IPEX] syndrome in humans 8, 9 and for wasting disease in scurfy mice. 10 Tregs can be divided into thymusderived naturally occurring Tregs [nTregs] and Tregs induced in peripheral tissues from the conversion of naïve conventional CD4 + T cells [iTregs] . 11 These iTregs suppress immune responses to both self and self-associated antigens, including those from food and commensal microbes. This seems of particular importance in the intestine as, unlike defects in nTregs which lead to widespread autoimmunity and inflammation, defects in iTregs lead primarily to intestinal inflammation.
These iTregs are generated by interaction with dendritic cells [DCs] and their development is dependent on the immunoregulatory cytokine TGF-β. Several populations of DCs are present in the lamina propria [LP] and the associated lymphoid tissues, such as mesenteric lymph nodes [MLN] , and among them, CD103 + DCs have the preferential ability to generate iTregs via TGF-ß and retinoic acid. 12, 13 iTregs seem to play a dominant role in the control of gut homeostasis, as demonstrated by the emergence of spontaneous colitis in mice lacking the CNS2 promoter region of the FOXP3 gene 14 or harbouring a defect of iTregs consecutive to defect in the integrin ß8 in DCs. 15, 16 Human studies have shown a partial defect in circulating Tregs in active IBD, 17, 18 that was compensated by increased Tregs in the gut LP 19 that retained a suppressive function. However, there is so far scarce information concerning the outcome of gut inflammation with regard to the fate and function of intestinal Tregs.
In this study, we document that Tregs only partially alleviate DSSinduced colitis and that colon inflammation primarily impairs de novo conversion of Tregs in MLN. 
Materials and Methods

Mice
DSS-induced colitis
Colitis was induced by administration of 3% DSS [w/v] [molecular weight (MW), 36 000-50 000; MP Biomedicals, Santa Anna, USA] in drinking water for 6 days, while control mice received water only. Mice were examined daily with respect to their general condition, body weight and consistency of stools. Mice were sacrificed on Day 6. Colon length and weight were measured and colon histology was carried out after fixation in 4% paraformaldehyde and haematoxylin and eosin [H&E] staining of paraffin-embedded sections [4 µm].
Foxp3 immunohistochemistry
Immunohistochemistry was performed on formalin-fixed, paraffinembedded tissue sections. Colon tissue samples were fixed in formalin and embedded in paraffin. We used Foxp3 polyclonal antibody [ab128800, Abcam, Cambridge, UK] at a dilution of 1:100. The immunohistochemical procedure was performed using a Ventana Benchmark autostainer [Ventana Medical Systems, Tucson, AZ, USA]. The detection system used diaminobenzidine as the chromogen. Slides were counterstained with haematoxylin. Stained slides were evaluated by a blinded experienced pathologist, and enumeration of Foxp3 positively stained cells was accomplished by count on five high-power microscopic fields [X200]. 
Depletion of regulatory T cells in DEREG mice
Results were analysed using StepOne software v2. 
Results
Foxp3 + Tregs alleviate the severity of DSSinduced colitis
To determine whether Tregs were able to control DSS-induced colitis, we used DEREG mice that express the DT receptor under the control of the Foxp3 promoter, which allows us to delete Tregs upon DT treatment. As expected, DT injection depleted more than 95% of Tregs in MLN and colon LP cells [ Figure 1A Figure 1C ]. These findings were corroborated by histological evaluation of H&E-stained colon cross-sections. We found a more severe colitis characterized by oedema, dense transmural lymphocytic inflammatory infiltrate and mucosal erosions in DT-treated DEREG mice orally exposed to DSS [ Figure 1D Thus, Tregs are required to limit the severity of DSS-induced colitis, even though they do not seem sufficient to prevent the development of gut inflammation, as Treg-repleted mice still develop colitis in this experimental setting.
DSS-induced colitis is associated with increased number of Tregs in MLN and colon LP
We next examined whether gut inflammation affected the frequency or number of Tregs. Leukocytes isolated from spleen, MLN and colon LP were analysed by flow cytometry after 3 or 6 days of DSS administration. While the body weight and the colon weight/length ratio changed significantly after 6 days of DSS compared with control mice, no evident sign of colitis was observed after 3 days of DSS exposure [ Figure Altogether, these results show that colitis in DSS-treated is not associated with a loss of Tregs, but on the contrary with an increase in Treg numbers both in MLN and colon LP. Figure 3C and D]. Ki67 expression levels in Tregs from either MLN [ Figure 3B ] or colon LP [ Figure 3D and 3E] were also higher in colitic vs control mice.
DSS colitis promotes Treg proliferation
Although Ki67 is a specific and quantitative indicator of recently expanded cells, its increase in Tregs of colitic mice does not formally indicate whether they retained their proliferative capacity. To address this issue, Tregs from MLN of DSS-treated or control mice were stained with CellTrace Violet and co-cultured for 5 days with naïve syngeneic DCs and anti-CD3 mAb. As shown in Figure 3F , Tregs from colitic and naïve mice exhibited a similar proliferative capacity. These data show that gut inflammation promotes Treg proliferation and that expanded cells retain thir ability to divide.
Enhanced suppressive function of colonic Tregs from DSS colitic mice
We next examined whether gut inflammation had an impact on the suppressive function of Tregs. To do so, we compared the ability of One possible explanation for the difference in suppressive activity between MLN and LP Tregs after DSS treatment could be the relative ratios of nTregs and iTregs in these compartments. It is known that the lamina propria contains a much greater proportion of iTregs compared with the MLN. 25 We therefore repeated the ex vivo suppression assay using MLN Tregs sorted on the basis of neuropillin-1 [NRP1] expression, a surface marker associated with nTregs 26, 27 . In control mice, CD4 -Tregs expressed slightly but significantly more Ki67 compared with NRP1 + Tregs and this expression was enhanced in the inflammatory condition in both Treg subsets [ Figure 4C ].
To get better insight into the mechanism behind the enhanced suppressive function of MLN NRP1 -Tregs from colitic mice, 
In vivo neoconversion of Tregs is impaired during DSS-induced colitis
We then examined the impact of colonic inflammation on Treg conversion, using two different in vivo Treg conversion models. In the second Treg differentiation model, we adoptively transferred FACS-sorted CD4 + CD25
+ Foxp3eGFP -cells in CD3ε KO mice [ Figure 6C ]. These cells were previously described by S. Schallenber et al. to be immediate precursors of Foxp3 + Tregs in homeostatic conditions. 23 Twelve days after in vivo i.v. transfer, we compared the frequency of converted Foxp3 + Tregs detected in MLN of CD3ε KO mice orally exposed with or without DSS. There was a roughly 2-fold less Foxp3 + Treg conversion in MLN from colitic mice compared with control [1.8 ± 0.5 % vs 3.6 ± 0.7 %, respectively; p = 0.03] [ Figure 6D ]. These data show that gut inflammation significantly reduces in vivo Foxp3 + Treg conversion in MLN.
Compromised Treg conversion property of DCs from DSS mice
DCs being integral to the differentiation of Tregs in the periphery, we next tested whether DCs from colitic mice were defective in their ability to induce Tregs in vitro. To this end, total CD11c + DCs from MLN of DSS-treated or control mice were co-cultured with naïve CD4 + CD25 -T cells sorted from RAG -/-OT-2 mice, in presence of TGF-β and OVA class-II peptide, and the frequency of Foxp3 + Tregs was assessed by flow cytometry after 5 days. We observed that DCs from colitic mice had a significantly reduced ability to induce Foxp3 + Tregs compared with control mice [3.9 ± 0.5 % vs 7.1 ± 0.8 %, respectively; p = 0.005] [ Figure 7A ]. MLN DCs can be subdivided into different subsets with distinct functions, and among them, CD103-expressing DCs are specialized for Treg generation. 12 
Discussion
Using the model of acute colitis induced by the gut barrier-disrupting agent DSS, we show that 32 Another possibility is that inability of Tregs to cope with colitis may be due to outnumbering of innate effectors of DSS colitis, which include neutrophils and macrophages. [33] [34] [35] Interestingly, it has been shown that nTregs and iTregs play a synergistic role in the control of colitis and that iTregs license nTregs regulatory properties. 36 We found that during inflammation, the suppressive function of NRP1 -Tregs in MLN, presumably representing iTreg, 37 was selectively increased; whereas that of NRP1 + Tregs, likely corresponding to constitutive nTregs, was unaffected by colitis. This may suggest that gut inflammation primarily influenced NRP1 -iTregs, although recent studies showed that NRP1 expression does not formally discriminate nTregs from iTregs and can be even transiently induced during the differentiation of iTregs from CD4 + T cells. 38 Our qPCR and cytometry data clearly show that NRP1 -Tregs are characterized by a high expression level of IL-10. Furthermore, the proportion of these cells is dramatically increased in MLN in the setting of DSS colitis. This difference in activation of iTregs vs nTregs might be due to the differential repertoire specificity of these cells, with nTregs being directed towards self-antigens whereas iTregs are specific for intestinal-associated antigens such as those derived from food or commensal flora. Peripheral Treg conversion takes place especially in MLN and in the gut LP. 12 13 We found that in vivo conversion of Foxp3 + Tregs was impaired in colitic mice, indicating that the inability of Tregs to completely alleviate colitis might be due to the opposing influence + MLN DCs play a critical role in Treg conversion, thanks at least in part to their ability to activate TGF-β via the integrin αvβ8. 16 We observed that the reduced ability of CD11c MLN DCs from colitic mice to promote Treg generation in vitro is associated with a decreased frequency of CD103 + DC subsets. Altogether, these data clearly show that gut inflammation promotes activation, proliferation and suppressive function of Tregs in the colon, whereas it impairs de novo conversion of naïve T cells into Tregs, thus likely contributing to inability to fully overcome intestinal inflammation. It could be proposed that Treg in IBD patients may not be intrinsically flawed, but may fail to suppress disease due to local factors inhibiting their permanent conversion from CD4 + T cells in the gut.
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